European Medicines Agency issues advice on sotrovimab (VIR-7831) for COVID-19, EMA

Following a review, the agency has concluded that sotrovimab, an investigation monoclonal antibody, can be used to treat confirmed COVID-19 in adults and adolescents (> 40 kg) who do not require supplemental oxygen therapy and are at risk of progressing to severe COVID-19.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news